{"id":"W2547144697","doi":"10.1016/j.ahj.2016.10.017","title":"Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study","year":2016,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Janssen Scientific Affairs; Janssen Pharmaceuticals; Bayer; AstraZeneca; Bristol-Myers Squibb; Amgen Canada; Amgen","keywords":"Medicine; Rivaroxaban; Stroke (engine); Antithrombotic; Clinical endpoint; Randomized controlled trial; Cardiology; Internal medicine; Atrial fibrillation; Surgery; Thrombosis; Pulmonary embolism; Myocardial infarction; Valve replacement; Warfarin; Stenosis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04202781,0.003978622,0.005886455,0.001094792,0.001383082,0.003349182,0.00217814,0.005737524,0.01366324],"category_scores_gemma":[0.03527685,0.001297493,0.003029743,0.00158056,0.002002897,0.001754875,0.001783859,0.004941707,0.003976638],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009898578,"about_ca_system_score_gemma":0.003310106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003674536,"about_ca_topic_score_gemma":0.0006064299,"domain_scores_codex":[0.952222,0.03926481,0.002423977,0.002964488,0.00202229,0.001102391],"domain_scores_gemma":[0.989901,0.004188723,0.001943497,0.001532655,0.001173451,0.001260655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.8060408,0.006012521,0.007875399,0.02264069,0.012204,0.0005672629,0.000617022,0.002461668,0.002695846,0.0258201,0.03127842,0.08178633],"study_design_scores_gemma":[0.8763252,0.03233112,0.004403293,0.003342687,0.006393367,0.0003103638,0.0001085219,0.005040746,0.0009089542,0.01423559,0.05645679,0.000143401],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.07837375,0.04545004,0.04743509,0.01683466,0.01447145,0.7642474,0.006808671,0.0007789035,0.02560003],"genre_scores_gemma":[0.1596211,0.007755191,0.04283006,0.01153589,0.005665762,0.7637609,0.001931929,0.0001487971,0.006750294],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.04202781,"threshold_uncertainty_score":0.222267,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03691441009692296,"score_gpt":0.3387189115074505,"score_spread":0.3018045014105276,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}